EVIDENCE THAT DOWN-REGULATION OF BETA-CELL GLUCOSE TRANSPORTERS IN NON-INSULIN-DEPENDENT DIABETES MAY BE THE CAUSE OF DIABETIC HYPERGLYCEMIA

被引:157
作者
ORCI, L
RAVAZZOLA, M
BAETENS, D
INMAN, L
AMHERDT, M
PETERSON, RG
NEWGARD, CB
JOHNSON, JH
UNGER, RH
机构
[1] UNIV TEXAS, SW MED CTR,CTR DIABET RES,GIFFORD LABS, DEPT INTERNAL MED, DALLAS, TX 75235 USA
[2] UNIV TEXAS, SW MED CTR, DEPT BIOCHEM, DALLAS, TX 75235 USA
[3] DEPT VET AFFAIRS MED CTR, DALLAS, TX 75235 USA
[4] UNIV GENEVA, SCH MED, DEPT MORPHOL, CH-1211 GENEVA 4, SWITZERLAND
[5] INDIANA UNIV, SCH MED, DEPT ANAT, INDIANAPOLIS, IN 46223 USA
关键词
D O I
10.1073/pnas.87.24.9953
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Non-insulin-dependent diabetes mellitus (NIDDM) is attributed to a failure of pancreatic β cells to maintain insulin secretion at a level sufficient to compensate for underlying insulin resistance. In the ZDF rat, a model of NIDDM that closely resembles the human syndrome, we have previously reported profound underexpression of GLUT-2, the high-Km facultative glucose transporter expressed by β cells of normal animals. Here we report that islets of diabetic rats exhibit a marked decrease in the volume density of GLUT-2-positive β cells and a reduction at the electron-microscopic level in the number of GLUT-2-immunoreactive sites per unit of β-cell plasma membrane. The deficiency of GLUT-2 cannot be induced in normal β cells by in vivo or in vitro exposure to high levels of glucose nor can it be prevented in β cells of prediabetic ZDF rats by elimination of hyperglycemia. We conclude that this dearth of immunodetectable GLUT-2 in NIDDM is not secondary to hyperglycemia and therefore that it may well play a causal role in the development of hyperglycemia.
引用
收藏
页码:9953 / 9957
页数:5
相关论文
共 29 条
[1]   SPECIMEN PREPARATION FOR ELECTRON-MICROSCOPY USING LOW-TEMPERATURE EMBEDDING RESINS [J].
ARMBRUSTER, BL ;
CARLEMALM, E ;
CHIOVETTI, R ;
GARAVITO, RM ;
HOBOT, JA ;
KELLENBERGER, E ;
VILLIGER, W .
JOURNAL OF MICROSCOPY-OXFORD, 1982, 126 (APR) :77-85
[2]  
BAETENS D, 1978, DIABETES, V27, P1, DOI 10.2337/diabetes.27.1.1
[3]   DECREASED SENSITIVITY OF PANCREATIC BETA CELLS TO GLUCOSE IN PREDIABETIC AND DIABETIC SUBJECTS - GLUCOSE DOSE-RESPONSE STUDY [J].
CERASI, E ;
EFENDIC, S ;
LUFT, R .
DIABETES, 1972, 21 (04) :224-&
[4]   REGULATION OF BETA-CELL GLUCOSE TRANSPORTER GENE-EXPRESSION [J].
CHEN, L ;
ALAM, T ;
JOHNSON, JH ;
HUGHES, S ;
NEWGARD, CB ;
UNGER, RH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (11) :4088-4092
[5]  
CLARK JB, 1983, P SOC EXP BIOL MED, V173, P68
[6]   ACARBOSE - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL [J].
CLISSOLD, SP ;
EDWARDS, C .
DRUGS, 1988, 35 (03) :214-243
[7]   STUDIES ON ANTIBODY PRODUCTION .1. A METHOD FOR THE HISTOCHEMICAL DEMONSTRATION OF SPECIFIC ANTIBODY AND ITS APPLICATION TO A STUDY OF THE HYPERIMMUNE RABBIT [J].
COONS, AH ;
LEDUC, EH ;
CONNOLLY, JM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1955, 102 (01) :49-+
[8]  
CREUTZFELDT W, 1982, INT C SERIES, V594
[9]   D-GLUCOSE TRANSPORT AND CONCENTRATION IN TUMORAL INSULIN-PRODUCING CELLS [J].
GIROIX, MH ;
SENER, A ;
MALAISSE, WJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1986, 251 (06) :C847-C851
[10]  
Goto Y, 1988, FRONTIERS DIABETES R, P301